(Sch 1000) -[:WAS_FOUND_TO_BE_EQUIPOTENT_IN_REDUCING_THE_AMOUNT_OF_BASAL_ACID]-> (oxazepam)
(Sch 1000) -[:PRODUCED_A_CLEAR_TREND_TOWARDS_LOWERED_MEAN_VALUES_DURING_STIMULATED_SECRETION]-> (acid)
(Sch 1000) -[:INCREASED_PH_VALUE_ONLY_DURING_BASAL_SECRETION_PERIOD]-> (pH)
(Oxazepam) -[:REDUCED_QUANTITY_OF_BASAL_ACID_ONLY_DURING_FIRST_30_MINUTES_OF_BASAL_SECRETION]-> (basal acid)
(Glycosidases) -[:ARE_OF_LYSOSOMAL_ORIGIN]-> (epidermis)
(Beta-galactosidase) -[:HAS_HIGH_ACTIVITY_IN_EPIDERMAL_GLYCOSIDASES]-> (glycosidases)
(Acid phosphatase) -[:IS_A_DISTINCT_ESTER_HYDROLASE_IN_GUINEA-PIG_EPIDERMIS]-> (ester hydrolases)
(Polycarboxyl groups) -[:POTENTIATE_AGGLUTINATION_OF_RED_CELLS]-> (agglutinin)
(Calcium ions) -[:CAN_CHELATE_WITH_POLYCARBOXYL_GROUPS_AND_INHIBIT_AGGLUTINATION]-> (polycarboxyl groups)
(Stroma from normal red cells) -[:INHIBITS_LYSIS_IN_SUCROSE_TEST_TO_SOME_EXTENT]-> (lysis)
(Stroma from PNH-like red cells) -[:ENHANCES_LYSIS_IN_ACIDIFIED-SERUM_TEST]-> (lysis)
(Complement activation through alternate pathway) -[:CAN_CONTROL_CLASSICAL_PATHWAY_ACTIVATION]-> (classical pathway)
(Histidine) -[:IS]-> (pKa of 6.4)
(Histidine) -[:HAS]-> (second-order velocity constant of 0.188 M-1 min-1)
(Alpha-lytic protease) -[:IS]-> (histidine with pKa of 6.5)
(Alpha-lytic protease) -[:HAS]-> (second-order velocity constant of 0.0235 M-1 min-1)
(Streptomyces griseus trypsin) -[:IS]-> (histidine with pKa of 6.5)
(Streptomyces griseus trypsin) -[:HAS]-> (second-order velocity constant of 0.0328 M-1 min-1)
(Valyl amino terminus) -[:IS]-> (pKa of 8.1)
(Valyl amino terminus) -[:HAS]-> (second-order velocity constant of 0.403 M-1 min-1)
(Lysine) -[:REACTS_WITH]-> (2,4-pentanedione at pH 7)
(Arginine) -[:REACTS_WITH]-> (2,4-pentanedione for long times at pH 9)
(Lysozyme) -[:IS_MODIFIED_BY]-> (3.8 lysine residues)
(Lysozyme) -[:REMAINS_MODIFIED_BY]-> (less than 0.4 arginine residue)
(Hemoglobin) -[:IS_SUSCEPTIBLE_TO_HYDROLYSIS_BY]-> (membraneous protease)
(Leucocytes) -[:CONTAIN]-> (erythrocyte membranes)
(Erythrocytes) -[:HAVE_MEMBRANEOUS_PROTEASES]-> (enzymes)
(Lysozyme) -[:FORMS_INTERPHASE_ADSORPTION_LAYERS_AT_LIQUID_BORDERS]-> (interfacial layer)
(Poly(L-glutamic acid)) -[:UNDERGOES_HELIX_TO_COIL_TRANSITION_IN]-> (solution)
(Potassium chloride solution) -[:ALLOWS_FOR_OBSERVATION_OF_POLYMER_CONCENTRATION_DEPENDENCE_OF_HELIX_TO_COIL_TRANSITION]-> (condition)
(Nitrofurazone) -[:IS_REDUCED_BY]-> (Escherichia coli)
(Oxygen) -[:INHIBITS]-> (Escherichia coli reductase IIa)
(DNA breakage) -[:CAN_BE_CAUSED_BY]-> (Unstable metabolites of nitrofurazone)
(Anaerobic conditions) -[:INCREASE_THE_ACTIVITY_OF]-> (Escherichia coli reductase IIb)
(Pseudomonas atlantica) -[:PRODUCES]-> (p-nitrophenyl alpha-galactose hydrolase)
(Pseudomonas atlantica) -[:PRODUCES]-> (neoagarobiose hydrolase)
(Thermophilic fungi) -[:CAN_GROW_ON]-> (Glucose-containing mineral medium)
(Phytophthora cinnamomi) -[:EXHIBITS_DIFFERENT_ENZYME_ACTIVITIES]-> (Nutrient-amended sterilized soil)
(HgCl2) -[:INHIBITS]-> (fatty acid synthetase)
(HgCl2) -[:INTERACTS_WITH]-> (sulfhydryl groups of fatty acid synthetase)
(N. nigricollis venom) -[:CONTAINS]-> (basic phospholipase A)
(basic phospholipase A) -[:REACTS_ON]-> (egg yolk lecithin)
(Sympathetic nervous system) -[:REGULATES_CEREBRAL_CIRCULATORY_RESPONSE_TO]-> (graded reductions in mean arterial blood pressure)
(Cerebral blood flow) -[:MAINTAINED_BY]-> (normal baboons)
(Superior cervical sympathectomy) -[:DOES_NOT_AFFECT]-> (normal response to graded reductions in mean arterial blood pressure)
(Alpha-receptor blockade) -[:ENHANCES_MAINTENANCE_OF]-> (cerebral blood flow)
(Phenoxybenzamine) -[:BLOCKS]-> (alpha-receptors)
(Cervical trunk division) -[:CAUSES]-> (acute surgical sympathectomy)
(Hypertensive rats) -[:EXHIBIT_HIGH_FREQUENCY_OF]-> (cerebral hemorrhage and periarteritis nodosa)
(Spontaneously hypertensive rats) -[:DEMONSTRATE_INCREASED_MORTALITY_COMPARED_TO]-> (normotensive and hypotensive controls)
(Myocardial infarction) -[:HAS]-> (Lactate dehydrogenase activity)
(Hepatocellular damage) -[:HAS]-> (Lactate dehydrogenase activity)
(Morphine poisoning) -[:HAS_INVERTED]-> (Hydroxypyruvate to pyruvate ratio)
(Procainamide) -[:CAN_BE_MEASURED_BY]-> (Fluorometric assay)
(N-acetylprocainamide) -[:CAN_BE_MEASURED_BY]-> (Fluorometric assay)
(Blood lactate) -[:CAN_BE_DIRECTLY_DETERMINED_IN]-> (Plasma)
(Lactate dehydrogenase) -[:IS_ASSAYED_USING]-> (Tris(hydroxymethyl)aminomethane hydrazine buffer)
(Amino acids) -[:ARE_SEPARATED_FROM]-> (Neutral amino acids)
(Gamma-glutamyl transpeptidase) -[:CAN_BE_MEASURED_BY]-> (Polyoxyethylene nonylphenol)
(Serum transpeptidase activity) -[:IS_ASSAYED_IN]-> (50 g/l of polyoxyethylene nonylphenol)
(Proteus mirabilis) -[:CONTAINS]-> (LD-carboxypeptidase)
(Proteus mirabilis) -[:CONTAINS]-> (DD-carboxypeptidase)
(Proteus mirabilis) -[:IS_INHIBITED_BY]-> (penicillin G)
(Clostridium pasteurianum) -[:HAS_A_PH_GRADIENT]-> (extracellular pH)
(Clostridium pasteurianum) -[:HAS_A_PH_GRADIENT]-> (intracellular pH)
(Clostridium pasteurianum) -[:HAS_A_PH_GRADIENT]-> (0.4-0.8 pH-units)
(Pigeon liver) -[:CONTAINS]-> (NAD kinase)
(Pigeon liver) -[:CONTAINS]-> (subunits of molecular weight 34000)
(Pigeon liver) -[:CONTAINS]-> (octomer)
(NAD+ (substrate)) -[:IS_BOUND_TO]-> (catalytic site)
(NAD+ (substrate)) -[:IS_BOUND_TO]-> (negative homotropic interactions)
(NADPH (inhibitor)) -[:INHIBITS]-> (NAD kinase activity)
(Pigeon liver) -[:REGULATES]-> (NAD kinase activity)
(Molybdenum ions) -[:INHIBIT_GROWTH_OF_YEASTS]-> (yeast cells)
(Aldoses) -[:DECREASE_INHIBITORY_EFFECT_OF_MOLYBDENUM_IONS_ON_YEAST_GROWTH]-> (molybdenum ions)
(Glucose transport system) -[:IS_SATURABLE_WITH_KM_OF_21.2_ÎœM_AND_V_OF_0.68_NMOL_MIN-1_(MG_PROTEIN)-1]-> (membrane vesicles isolated from Acholeplasma laidlawii)
(4-deoxy-D-glucose) -[:IS_TRANSPORTED_INTO_SACCHAROMYCES_CEREVISIAE_BY_THE_CONSTITUTIVE_GLUCOSE_CARRIER]-> (Saccharomyces cerevisiae)
(Gluconic acid production) -[:IS_STIMULATED_BY_ADDITION_OF_LOW_CONCENTRATIONS_OF_KH2PO4_AND_MGSO4_-_7_H2O]-> (Penicillium species)
(Penicillium puberulum) -[:PRODUCES_THE_MAXIMUM_YIELD_OF_GLUCONIC_ACID_(91%)_IN_SURFACE_CULTURE]-> (gluconic acid)
(Glucose) -[:IS_SUPERIOR_TO_SUCROSE_AS_A_NITROGEN_SOURCE_FOR_ACID_FERMENTATION]-> (Peptone)
(PR-D-92-EA) -[:BLOCKS]-> (50% of response)
(PR-D-92-EA) -[:BLOCKS]-> (histamine response)
(PR-D-92-EA) -[:BLOCKS]-> (bradykinin response)
(PR-D-92-EA) -[:BLOCKS]-> (serotonin response)
(PR-D-92-EA) -[:BLOCKS]-> (prostaglandin E2 response)
(PR-D-92-EA) -[:BLOCKS]-> (prostaglandin F2ALPHA response)
(PR-D-92-EA) -[:BLOCKS]-> (slow-reacting substance of anaphylaxis response)
(N-acetyl dehydroalanine methyl ester) -[:IS_HYDROLYZED_BY]-> (ester group C-O bond)
(N-acetyl dehydroalanine methyl ester) -[:IS_HYDROLYZED_BY]-> (acetamido group C-N bond)
(Urecholine) -[:INCREASES]-> (spontaneous activity)
(Urecholine) -[:INCREASES]-> (mean tension)
(Urecholine) -[:INCREASES]-> (frequency of contraction)
(Ophthalmologist) -[:DELEGATES_RESPONSIBILITY_TO]-> (staff)
(Ophthalmologist) -[:ACHIEVES_PERSONAL_SATISFACTION_THROUGH]-> (traffic flow techniques)
(Patient-physician relationship) -[:IS_THE_CORNERSTONE_OF]-> (private practice of ophthalmology)
(Urinary bladder smooth muscle strips) -[:RESPOND_TO_URECHOLINE_WITH]-> (spontaneous activity)
(Urinary bladder smooth muscle strips) -[:SHOW_CONTRACTILE_DEVIATION_AT]-> (3.0 to 6.0 muM)
(Histologic examination) -[:SHOWS_LONGITUDINALLY_ORIENTED_MUSCLE_BUNDLES_WITH_MULTIPLE_ANASTOMOSING_IN]-> (urinary bladder smooth muscle strips)
(Behavior Modification Training Program) -[:IS_PRIMARILY_GEARED_TOWARDS_TRAINING_OF]-> (paraprofessionals)
(Behavior Modification Training Program) -[:INCLUDES_INSTRUCTION_IN_TECHNIQUES_OF_RELAXATION_AND_DESENSITIZATION_FOR]-> (staff working with drug addicts)
(Diplococcus pneumoniae) -[:HAS_ENZYME]-> (deoxyribonuclease I)
(Diplococcus pneumoniae) -[:HAS_ENZYME]-> (autolysin)
(Diplococcus pneumoniae) -[:HAS_ENZYME]-> (amylomaltase)
(Diplococcus pneumoniae) -[:HAS_ENZYME]-> (exonuclease 1)
(Diplococcus pneumoniae) -[:HAS_ENZYME]-> (deoxyribonuclease 2)
(Bacillus cereus) -[:HAS_ENZYME]-> (dihydrodipicolinic acid synthase)
(Salmonella typhimurium) -[:HAS_ENZYME]-> (3-deoxy-D-arabino-heptulosonic acid 7-phosphate synthase)
(Salmonella typhimurium) -[:HAS_ENZYME]-> (aroG)
(Salmonella typhimurium) -[:HAS_ENZYME]-> (aroH)
(Salmonella typhimurium) -[:HAS_ENZYME]-> (aroF)
(Bacillus cereus) -[:HAS_ENZYME]-> (specific activity)
(Diplococcus pneumoniae) -[:IS_CAPABLE_OF]-> (genetic transformation)
(Alpha-lactalbumin) -[:IS]-> (globular protein)
(Alpha-lactalbumin) -[:UNDERGOES_CONFORMATIONAL_TRANSITION]-> (acid conformational change)
(Cathepsin A) -[:HAS_MULTIPLE_FORMS]-> (AI, AII, and AIII)
(Cathepsin A) -[:IS_INHIBITED_BY]-> (Ag+)
(Cathepsin A) -[:IS_INHIBITED_BY]-> (Au3+)
(Cathepsin A) -[:IS_INHIBITED_BY]-> (Hg2+)
(CBZ-Glu-Phe) -[:IS_A_SUBSTRATE_FOR]-> (cathepsin A)
(CBZ-Glu-Phe) -[:HAS_OPTIMAL_PH_FOR_ACTIVITY]-> (5.6, 5.8, and 5.9)
(Cathepsin A) -[:HAS_ISOELECTRIC_POINT_AT]-> (4.7, 4.8, and 4.9)
(NADH-coenzyme Q reductase) -[:IS]-> (complex I)
(Coenzyme Q1) -[:IS_REDUCED_BY]-> (NADH)
(Proton translocation) -[:OCCURS_DURING]-> (electron transfer)
(Valinomycin) -[:STIMULATES]-> (uncoupling of energy coupling)
(Tetraphenylboron) -[:IS_TAKEN_UP_BY]-> (reconstituted vesicles)
(Sn-glycerol-3-phosphate acyltransferase) -[:HAS_HIGH_SPECIFICITY_FOR]-> (acyl thiolester derivatives of ACP)
(Acyl carrier protein (ACP)) -[:IS_USED_AS_ACYL_DONOR]-> (sn-glycerol-3-phosphate acyltransferase)
(Oleyl-ACP) -[:IS_USED_AS_ACYL_SUBSTRATE]-> (sn-glycerol-3-phosphate acyltransferase)
(Palmityl-ACP) -[:IS_USED_AS_ACYL_SUBSTRATE]-> (sn-glycerol-3-phosphate acyltransferase)
(Lysophosphatidic acid) -[:IS_A_PRODUCT_OF]-> (reaction with sn-glycerol-3-phosphate acyltransferase)
(Phosphatidic acid) -[:IS_A_PRODUCT_OF]-> (reaction with sn-glycerol-3-phosphate acyltransferase)
(Monoglyceride) -[:IS_A_PRODUCT_OF]-> (reaction with sn-glycerol-3-phosphate acyltransferase)
(Acid DNase) -[:IS]-> (beef liver)
(Phosphodiesterase) -[:IS]-> (acid deoxyribonuclease contaminant)
(Molecular weight) -[:EQUALS]-> (26,500)
(Inhibitor) -[:BINDS_TO]-> (catalytic site of acid DNase)
(ATP) -[:IS_USED_FOR]-> (motility by energy-transducing protein(s) called dynein)
(Guanine nucleotides) -[:ARE_PREREQUISITES_FOR]-> (assembly of microtubules)
(Dynein) -[:CAN_BE_SOLUBILIZED_FROM]-> (Chlamydomonas flagella as a heterogeneous, Mg2+ or Ca2+-activated ATPase)
(Ca2+) -[:IS_REQUIRED_FOR]-> (activity of homogeneous, low molecular weight, Ca2+-specific adenosine triphosphatase)
(Mg2+) -[:INHIBITS]-> (activity of homogeneous, low molecular weight, Ca2+-specific adenosine triphosphatase)
(Adenylate kinase) -[:IS_INVOLVED_IN]-> (regenerating flagella)
(Nucleoside diphosphokinase) -[:CO-POLYMERIZES_WITH]-> (tubulin purified by repeated cycles of polymerization)
(Arginine kinase) -[:IS_NOT_DETECTED_IN]-> (Chlamydomonas flagellar extracts)
(Chediak-Higashi syndrome) -[:IS_CHARACTERIZED_BY]-> (giant lysosomes)
(Coronary vein arterialization) -[:TREATS]-> (acute myocardial ischaemia)
(Androgenic hormones) -[:CAUSE]-> (elevation in kidney lysosomal enzyme beta-glucuronidase)
(Kidney tubule cells) -[:CONTAIN]-> (giant glucuronidase-containing lysosomes)
(Lysosomes) -[:MAY_ACCUMULATE_DUE_TO]-> (defective exocytosis)
(Ethidium bromide) -[:STIMULATES]-> (membrane associated process of sugar transport)
(Virus transformed cells) -[:HAVE]-> (altered plasma and subcellular membrane glycoproteins)
(Coronary sinus) -[:IS_TREATED_WITH]-> (selective arterialization)
(Coronary arteriosclerosis) -[:IS_TREATED_WITH]-> (regional vein arterialization)
(Kidney beta-glucuronidase) -[:IS_INCREASED_IN]-> (beige mice treated with androgen)
(Propranolol) -[:IS_BOUND_TO]-> (NADPH)
(Glucose 6-phosphate dehydrogenase) -[:IS_ASSOCIATED_WITH]-> (NADPH)
(4-Hydroxypropranolol) -[:IS_AN_ACTIVE_METABOLITE_OF]-> (Propranolol)
(Oxprenolol) -[:IS_USED_AS_INTERNAL_STANDARD_FOR]-> (Propranolol and 4-hydroxypropranolol)
(Delta9-tetrahydrocannabinol) -[:IS_A_COMPONENT_OF]-> (Cannabis)
(Asparagine) -[:CAN_BE_SEPARATED_FROM]-> (Glutamine and Glutamic acid)
(BW 59C) -[:IS_ASSAYED_IN]-> (Human plasma, urine and faeces)
(Lorazepam) -[:IS_EQUIVALENT_TO]-> (Pentobarbital)
(Strontium) -[:CAN_SIGNIFICANTLY_REDUCE]-> (Demineralization of hydroxyapatite)
(Histamine) -[:SYNERGISTICALLY_TRIGGERS]-> (Bone marrow reactions)
(Antihistamines) -[:HINDER_THE_PROCESS_OF]-> (Bone marrow reactions)
(Mitochondria) -[:FOLLOW_A_SIMILAR_PATTERN_OF]-> (Organelle increase)
(Peroxisomes) -[:PARALLEL_THE_INCREASE_IN_NUMBER_OF]-> (Endoplasmic reticulum)
(Diphenhydramine) -[:INHIBITS_BONE_MARROW_REACTIONS]-> (Endotoxin)
(Promethazine) -[:INHIBITS_BONE_MARROW_REACTIONS]-> (Endotoxin)
(Chlorpromazine) -[:INHIBITS_BONE_MARROW_REACTIONS]-> (Endotoxin)
(Cyproheptadine) -[:INHIBITS_BONE_MARROW_REACTIONS]-> (Endotoxin)
(Histamine) -[:IS_ASSOCIATED_WITH]-> (Allergic Rhinitis)
(Histamine) -[:IS_ASSOCIATED_WITH]-> (Asthma)
(Visual Pigment) -[:IS_ATTACHED_TO]-> (Opsin)
(Light) -[:CAUSES]-> (Isomerization of Chromophore)
(Light) -[:CAUSES]-> (Hyperpolarization of Membrane)
(Chloride) -[:CROSSES_MEMBRANE_AS]-> (Dimer of HCl)
(pH) -[:AFFECTS]-> (Extent of Inhibition by Phloretin)
(pH) -[:AFFECTS]-> (Activation Energy for Chloride Exchange)
(Acetylcholine) -[:REVERSAL_POTENTIAL]-> (-3mV)
(Myotubes) -[:ACTIVATED_RECEPTOR]-> (permeable to K+ and Na+ ions)
(Tris+) -[:ION_PERMEABILITY]-> (myotubes)
(Ca++) -[:EXTERNAL_CONCENTRATION]-> (insensitive to Er magnitude)
(pH) -[:EXTERNAL_PH_RANGE]-> (insensitive to Er magnitude)
(Equivalent circuit equation) -[:DESCRIBES_ER_OF_ADULT_RAT_MUSCLE]-> (adult rat muscle)
(Adult frog muscle) -[:DESCRIBED_BY_EQUIVALENT_CIRCUIT_EQUATION]-> (equivalent circuit equation)
(Myotubes) -[:CONTAINS_ACETYLCHOLINE_RECEPTORS]-> (activated receptor)
(Acetylcholine) -[:TRANSMITTER_ROLE]-> (myotubes)
(Receptor) -[:BINDING_SITE_FOR_ACETYLCHOLINE]-> (acetylcholine)
(Ion channel) -[:STRUCTURE_OF_ACTIVATED_RECEPTOR]-> (permeable to K+ and Na+ ions)
(NADH oxidase) -[:ENZYME_INVOLVED_IN_METHANE_OXIDATION]-> (methane-dependent NADH oxidation)
(Mono-oxygenase) -[:ENZYME_INVOLVED_IN_CO_OXIDATION]-> (CO-dependent CO2 formation)
(Ethanol metabolism) -[:UNLIKELY_TO_RESULT_IN_SUBSTRATE-LEVEL_NADH_PRODUCTION]-> (P. methanica)
(Relaxation technique) -[:USED_TO_REDUCE_ANXIETY_AND_NEGATIVE_INTERPERSONAL_CONSEQUENCES]-> (subject)
(Imaginal scenes) -[:USED_FOR_SYSTEMATIC_DESENSITIZATION]-> (subject)
(Therapist) -[:PROVIDED_SUGGESTIONS_DURING_SYSTEMATIC_DESENSITIZATION]-> (subject)
(Dopamine) -[:INTRACISTERNALLY_ADMINISTERED_SUBSTANCE]-> (basilar artery)
(Cerebral vasospasm) -[:GENERATED_BY_DOPAMINE_IN_BASILAR_ARTERY]-> (dopamine)
(Prostaglandin E2) -[:COMPARED_TO_DOPAMINE_FOR_VASOSPASM_INDUCTION]-> (basilar artery)
(pH) -[:IS_AFFECTED_BY]-> (buffer concentration)
(velocity constant) -[:DECLINES_WITH]-> (hydrogen-ion concentration)
(apparent solubility) -[:INCREASES_BY]-> (complexation with gentisic acid)
(proteolytic activity) -[:IS_INHIBITED_BY]-> (dioctyl sodium sulfosuccinate)
(antidiarrheal effect) -[:IS_MODIFIED_BY]-> (activated charcoal powder)
(bioavailability) -[:IS_AFFECTED_BY]-> (activated charcoal powder)
(antipropulsive action) -[:IS_STRONGLY_INHIBITED_BY]-> (activated charcoal powder)
(GI transit) -[:CAN_BE_STUDIED_WITH]-> (chromium oxide)
(Tetrodotoxin) -[:DECREASES]-> (Na permeability)
(Tetrodotoxin) -[:DECREASES]-> (active cationic form)
(Tetrodotoxin) -[:AFFECTS]-> (offset rate)
(Tetrodotoxin) -[:AFFECTS]-> (onset time constant)
(Synapse formation) -[:INDUCES]-> (refractory property)
(Synapse formation) -[:CONSTRAINS]-> (synapse formation to specific sites)
(Psychotropic tablets) -[:PRESCRIBED_BY]-> (general practitioner)
(Psychotropic tablets) -[:TREATED_WITH]-> (diagnostic group)
(Hospital referrals) -[:RECORDED_FOR]-> (longer period)
(Overdoses) -[:RECORDED_FOR]-> (longer period)
